Kevin Warsh leaves Coupang (NYSE: CPNG) board after taking Federal Reserve Chair role
Filing Impact
Filing Sentiment
Form Type
8-K/A
Rhea-AI Filing Summary
Coupang, Inc. reports that director Kevin M. Warsh has resigned from its board after being confirmed by the U.S. Senate as Chairman of the Board of Governors of the U.S. Federal Reserve System. The resignation became effective immediately upon his confirmation.
Because U.S. federal ethics and conflict of interest rules prevent holding both positions, Warsh chose the Federal Reserve role. The company states his decision was not due to any disagreement over its operations, policies, or practices. He will not stand for re-election, any votes for him will not be counted, and the board will reduce its size by one director.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Confirmation date as Federal Reserve Chair: May 13, 2026
Effective timing of resignation: Immediate on May 13, 2026
Board size change: 1 seat reduction
3 metrics
Confirmation date as Federal Reserve Chair
May 13, 2026
U.S. Senate confirmation of Kevin M. Warsh
Effective timing of resignation
Immediate on May 13, 2026
Warsh resigned as director effective upon confirmation
Board size change
1 seat reduction
Board will reduce size by one director after resignation
Key Terms
Federal Reserve Chair, emerging growth company, conflict of interest, annual meeting of stockholders
4 terms
Federal Reserve Chair financial
"to serve as Chairman of the Board of Governors of the United States Federal Reserve System (“Federal Reserve Chair”)"
emerging growth company regulatory
"405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
conflict of interest regulatory
"Under applicable U.S. federal ethics and conflict of interest requirements, Mr. Warsh cannot hold both positions"
annual meeting of stockholders financial
"he will no longer stand for re-election as a director at the Company’s upcoming annual meeting of stockholders"
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||||||||
(Address of principal executive offices, including zip code)
(206 ) 333-3839
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously disclosed in the Current Report on Form 8-K filed on February 6, 2026 by Coupang, Inc. (the “Company”) with the U.S. Securities and Exchange Commission, on January 30, 2026, President Donald J. Trump announced his intent to nominate Kevin M. Warsh, a member of the board of directors of the Company (the “Board”), to serve as Chairman of the Board of Governors of the United States Federal Reserve System (“Federal Reserve Chair”), subject to confirmation by the United States Senate (the “U.S. Senate”). On February 3, 2026, Mr. Warsh informed the Company that if he is confirmed as Federal Reserve Chair by the U.S. Senate, he would resign as a director of the Company.
On May 13, 2026, the U.S. Senate confirmed Mr. Warsh as Federal Reserve Chair and Mr. Warsh resigned as a director of the Company effective immediately. Under applicable U.S. federal ethics and conflict of interest requirements, Mr. Warsh cannot hold both positions as Federal Reserve Chair and as a Company director. Mr. Warsh’s decision was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.
As a result of Mr. Warsh’s resignation, he will no longer stand for re-election as a director at the Company’s upcoming annual meeting of stockholders, no votes received will be counted for or against the election of Mr. Warsh to the Board, and the Board will reduce the size of the Board by one director.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| COUPANG, INC. | |||||
| By: | /s/ Harold L. Rogers | ||||
| Name: | Harold L. Rogers | ||||
| Title: | General Counsel and Chief Administrative Officer | ||||
Dated: May 14, 2026
FAQ
Why did Kevin Warsh resign from Coupang (CPNG)’s board?
Kevin Warsh resigned from Coupang’s board after the U.S. Senate confirmed him as Federal Reserve Chair. U.S. federal ethics and conflict of interest rules prevent him from serving simultaneously as Federal Reserve Chair and as a Coupang director, so he stepped down immediately.
When was Kevin Warsh confirmed as Federal Reserve Chair while on Coupang’s board?
Kevin Warsh was confirmed by the U.S. Senate as Federal Reserve Chair on May 13, 2026, while serving as a Coupang director. His resignation from Coupang’s board became effective immediately upon that confirmation, consistent with federal ethics and conflict requirements.
Did Kevin Warsh have any disagreements with Coupang (CPNG) before resigning?
Coupang states that Kevin Warsh’s decision to resign from its board was not due to any disagreement with the company. This includes no disagreements regarding Coupang’s operations, policies, or practices, indicating the departure is driven solely by his new public role.
How does Kevin Warsh’s resignation affect Coupang’s upcoming annual meeting?
Because Kevin Warsh resigned, he will no longer stand for re-election at Coupang’s upcoming annual meeting. Any votes submitted for or against his election will not be counted, and the board has decided to reduce its size by one director position accordingly.
What governance change did Coupang (CPNG) make after Warsh’s resignation?
Following Kevin Warsh’s resignation from the board, Coupang decided to reduce the size of its board by one director. This means the company will not fill his seat immediately, aligning the number of directors with those standing for election at the annual meeting.